Ye, F., Gao, T., Xie, L., Wu, C., Min, L., Yang, K. (2025). Phase Ib trial of C019199, an oral TME modulator targeting CSF-1R/DDRs/VEGFR2, in relapsed or refractory osteosarcoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.11510